Laudanno O, Ahumarán G, Gollo P, Khoury M, Thomé M, González P. Tailored Helicobacter pylori eradication therapy in obese patients undergoing bariatric surgery.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 2020;
113:345-347. [PMID:
33244981 DOI:
10.17235/reed.2020.7433/2020]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
OBJECTIVES
to compare the efficacy and safety of a tailored quadruple concomitant therapy based on body weight, with the same scheme but with fixed doses in obese patients undergoing bariatric surgery.
METHODS
a prospective study was performed of 104 obese patients.
RESULTS
the weight-based therapy group achieved significantly higher eradication rates in the intention-to-treat analysis; 86.3 % (95 % CI: 74.3-93.2) vs 66.1 % (95 % CI: 52.6-77.3), p < 0.05. Relative risk: 1.31 (95 % CI: 1.05-1.63). Discontinuations and adverse events were similar in both groups.
CONCLUSIONS
a tailored quadruple concomitant therapy based on body weight seems to be more effective than the standard quadruple concomitant therapy in obese patients.
Collapse